𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia

✍ Scribed by David A. Rizzieri; Jenny A. O'Brien; Gloria Broadwater; Carlos M. Decastro; Prakash Dev; Louis Diehl; Anne Beaven; Anand Lagoo; Jon P. Gockerman; Nelson J. Chao; Joseph O. Moore

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
208 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Relationship between patients' age, bone
Relationship between patients' age, bone marrow karyotype, and outcome of induction therapy in acute myelogenous leukemia
✍ Dr. Ph. Bernard; F. Lacombe; J. Reiffers; B. David; G. Marit; M. J. Bourdeau; A. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 351 KB πŸ‘ 1 views

Bone marrow karyotypes were performed in 88 cases of adult acute myelogenous leukemia (AML) at diagnosis and classified NN (normal), AA (abnormal), and AN (mixture of normal and abnormal metaphases). A clear relationship was found between karyotype and complete remission (CR) rate: 58% CR in (NN + A

Predictors of response to reinduction ch
Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy
✍ Joseph M. Brandwein; Vikas Gupta; Andre C. Schuh; Aaron D. Schimmer; Karen Yee; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

## Abstract Eighty‐one patients with acute myeloid leukemia who had persistent leukemia following standard induction therapy with cytarabine plus daunorubicin (7+3 regimen) underwent reinduction therapy with a combination of mitoxantrone, etoposide, and high‐dose cytarabine (HiDAC). Patients achiev